3D printed dual macro-, microscale porous network as a tissue engineering scaffold with drug delivering function

被引:56
作者
Hoang Phuc Dang [1 ,2 ]
Shabab, Tara [1 ,2 ]
Shafiee, Abbas [2 ,3 ]
Peiffer, Quentin C. [1 ,2 ]
Fox, Kate [1 ,4 ]
Nhiem Tran [5 ]
Dargaville, Tim R. [6 ]
Hutmacher, Dietmar W. [1 ,2 ]
Tran, Phong A. [1 ,2 ,7 ]
机构
[1] QUT, ARC Ctr Addit Biomfg, Brisbane, Qld, Australia
[2] QUT, Inst Hlth & Biomed Innovat, Ctr Regenerat Med, Brisbane, Qld, Australia
[3] Univ Queensland, UQ Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia
[4] RMIT Univ, Ctr Addit Mfg, Sch Engn, Melbourne, Vic, Australia
[5] RMIT Univ, Sch Sci, Melbourne, Vic, Australia
[6] QUT, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia
[7] QUT, Sch Chem Phys & Mech Engn, Interface Sci & Mat Engn Grp, Brisbane, Qld, Australia
关键词
scaffold; drug delivery; tumor recurrence; 3d printing; porous; tissue engineering; infection; ADVANCED BREAST-CANCER; NANOPARTICLES; PACLITAXEL; DOXORUBICIN; FORMULATION; CEFAZOLIN; FILMS; PHARMACOKINETICS; PROPHYLAXIS; IMPLANTS;
D O I
10.1088/1758-5090/ab14ff
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Tissue engineering macroporous scaffolds are important for regeneration of large volume defects resulting from diseases such as breast or bone cancers. Another important part of the treatment of these conditions is adjuvant drug therapy to prevent disease recurrence or surgical site infection. In this study, we developed a new type of macroporous scaffolds that have drug loading and release functionality to use in these scenarios. 3D printing allows for building macroporous scaffolds with deterministically designed complex architectures for tissue engineering yet they often have low surface areas thus limiting their drug loading capability. In this proof-of-concept study, we aimed to introduce microscale porosity into macroporous scaffolds to allow for efficient yet simple soak-loading of various clinical drugs and control their release. Manufacturing of scaffolds having both macroporosity and microscale porosity remains a difficult task. Here, we combined porogen leaching and 3D printing to achieve this goal. Porogen microparticles were mixed with medical grade polycaprolactone and extruded into scaffolds having macropores of 0.7 mm in size. After leaching, intra-strut microscale pores were realized with pore size of 20-70 mu m and a total microscale porosity of nearly 40%. Doxorubicin (DOX), paclitaxel (PTX) and cefazolin (CEF) were chosen as model drugs of different charges and solubilities to soak-load the scaffolds and achieved loading efficiency of over 80%. The microscale porosity was found to significantly reduce the burst release allowing the microporous scaffolds to release drugs up to 200, 500 and 150 h for DOX, PTX and CEF, respectively. Finally, cell assays were used and confirmed the bioactivities and dose response of the drug-loaded scaffolds. Together, the findings from this proof-of-concept study demonstrate a new type of scaffolds with dual micro-, macro-porosity for tissue engineering applications with intrinsic capability for efficient loading and sustained release of drugs to prevent post-surgery complications.
引用
收藏
页数:16
相关论文
共 91 条
[1]   Efficacy and pharmacokinetics of site-specific cefazolin delivery using biodegradable implants in the prevention of post-operative wound infections [J].
Allababidi, S ;
Shah, JC .
PHARMACEUTICAL RESEARCH, 1998, 15 (02) :325-333
[2]  
[Anonymous], 2016, NAT REV MATER
[3]   IONIZATION OF PHENOLIC AMINES, INCLUDING APOMORPHINE, DOPAMINE AND CATECHOLAMINES AND AN ASSESSMENT OF ZWITTERION CONSTANTS [J].
ARMSTRONG, J ;
BARLOW, RB .
BRITISH JOURNAL OF PHARMACOLOGY, 1976, 57 (04) :501-516
[4]   The effect of pore size on tissue ingrowth and neovascularization in porous bioceramics of controlled architecture in vivo [J].
Bai Feng ;
Zhang Jinkang ;
Wang Zhen ;
Lu Jianxi ;
Chang Jiang ;
Liu Jian ;
Meng Guolin ;
Dong Xin .
BIOMEDICAL MATERIALS, 2011, 6 (01)
[5]   Three-Dimensional Printing in Plastic and Reconstructive Surgery A Systematic Review [J].
Bauermeister, Adam J. ;
Zuriarrain, Alexander ;
Newman, Martin I. .
ANNALS OF PLASTIC SURGERY, 2016, 77 (05) :569-576
[6]   Characterisation of freeze-dried wafers and solvent evaporated films as potential drug delivery systems to mucosal surfaces [J].
Boateng, Joshua S. ;
Auffret, Anthony D. ;
Matthews, Kerr H. ;
Humphrey, Michael J. ;
Stevens, Howard N. E. ;
Eccleston, Gillian M. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 389 (1-2) :24-31
[7]   Modifying release characteristics from 3D printed drug-eluting products [J].
Boetker, Johan ;
Water, Jorrit Jeroen ;
Aho, Johanna ;
Arnfast, Laerke ;
Bohr, Adam ;
Rantanen, Jukka .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 90 :47-52
[8]  
Chao TC, 2005, INVEST NEW DRUG, V23, P171
[9]   Transformation of Breast Reconstruction via Additive Biomanufacturing [J].
Chhaya, Mohit P. ;
Balmayor, Elizabeth R. ;
Hutmacher, Dietmar W. ;
Schantz, Jan-Thorsten .
SCIENTIFIC REPORTS, 2016, 6
[10]   Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles [J].
Choi, Chung Hang J. ;
Alabi, Christopher A. ;
Webster, Paul ;
Davis, Mark E. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (03) :1235-1240